Skip to main content
Top
Published in: Intensive Care Medicine 10/2005

01-10-2005 | Original

Thyroid hormone levels improve the prediction of mortality among patients admitted to the intensive care unit.

Authors: Erick Chinga-Alayo, Jaime Villena, Arthur T. Evans, Mirko Zimic

Published in: Intensive Care Medicine | Issue 10/2005

Login to get access

Abstract

Objective

As hormones are strongly associated with mortality in critically ill patients, we investigated whether mortality prediction based on the Acute Physiology and Chronic Health Evaluation (APACHE) is improved by combining this score with hormone measurements.

Design and setting

Intensive care units in three hospitals

Patients and participants

113 patients admitted to.

Measurements

Within the first hour after ICU admission we measured total triiodothyronine, total thyroxine, free thyroxine, thyrotropin, cortisol, growth hormone, dehydroepiandrosterone, and prolactin levels and administered the APACHE. Patients were followed until they died or were discharged from the ICU.

Results

The best logistic regression model for ICU mortality included the APACHE score and thyroid-stimulating hormone and triiodothyronine levels. This model had an area under the receiver operating characteristic curve of 0.88, significantly higher than the APACHE score alone with 0.75. The model with hormone levels and APACHE score was also significantly better calibrated than the model with only the APACHE score.

Conclusions

The addition of thyroid hormones to the APACHE score improves the prediction of mortality for ICU patients
Literature
1.
go back to reference Civetta JM (1997) Prediction and definition of outcome. In: Civetta JM, Taylor RW, Kirby RR (ed) Critical care. Lippincott-Raven, Philadelphia, pp 127–147 Civetta JM (1997) Prediction and definition of outcome. In: Civetta JM, Taylor RW, Kirby RR (ed) Critical care. Lippincott-Raven, Philadelphia, pp 127–147
2.
go back to reference Jarek MJ, Legare EJ, McDermott MT, JA, Kollef MH (1993) Endocrine profiles for outcome prediction from the intensive care unit. Crit Care Med 21:543–550PubMed Jarek MJ, Legare EJ, McDermott MT, JA, Kollef MH (1993) Endocrine profiles for outcome prediction from the intensive care unit. Crit Care Med 21:543–550PubMed
3.
go back to reference Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1986) An evaluation of outcome from intensive care in major medical center. Ann Intern Med 104:410–418PubMed Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1986) An evaluation of outcome from intensive care in major medical center. Ann Intern Med 104:410–418PubMed
4.
go back to reference Schafer JH, Maurer A, Jochimsen F, Emde C, Wegscheider K, Arntz HR, Heitz J, Krell-Schroeder B, Distler A (1990) Outcome prediction models on admission in a medical intensive unit: do they predict individual outcome? Crit Care Med 18:1111–1117PubMed Schafer JH, Maurer A, Jochimsen F, Emde C, Wegscheider K, Arntz HR, Heitz J, Krell-Schroeder B, Distler A (1990) Outcome prediction models on admission in a medical intensive unit: do they predict individual outcome? Crit Care Med 18:1111–1117PubMed
5.
go back to reference Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13:818–829PubMed Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13:818–829PubMed
6.
go back to reference Rothwell PM, Lawler PG (1995) Prediction of outcome in intensive care patients using endocrine parameters. Crit Care Med 23:78–83PubMed Rothwell PM, Lawler PG (1995) Prediction of outcome in intensive care patients using endocrine parameters. Crit Care Med 23:78–83PubMed
7.
go back to reference Rolih CA, Ober KP (1995) The endocrine response to critical illness. Med Clin North Am 79:211–224PubMed Rolih CA, Ober KP (1995) The endocrine response to critical illness. Med Clin North Am 79:211–224PubMed
8.
go back to reference Sumita S, Ujike Y, Namiki A, Watanabe H, Kawamata M, Watanabe A, Satoh O (1994) Suppression of the thyrotropin response to thyrotropin-releasing hormone and its association with severity of critical illness. Crit Care Med 22:1603–1609PubMed Sumita S, Ujike Y, Namiki A, Watanabe H, Kawamata M, Watanabe A, Satoh O (1994) Suppression of the thyrotropin response to thyrotropin-releasing hormone and its association with severity of critical illness. Crit Care Med 22:1603–1609PubMed
9.
go back to reference Finlay WEI, McKee JI (1982) Serum Cortisol levels in severely stressed patients. Lancet I:1414–1415 Finlay WEI, McKee JI (1982) Serum Cortisol levels in severely stressed patients. Lancet I:1414–1415
10.
go back to reference Rothwell PM, Udwadia ZF, Lawler PG (1993) Thyrotropin concentration predicts outcome in critical illness. Anaesthesia 48:373–376PubMed Rothwell PM, Udwadia ZF, Lawler PG (1993) Thyrotropin concentration predicts outcome in critical illness. Anaesthesia 48:373–376PubMed
11.
go back to reference Kaptein EM, Weiner JM, Robinson WJ, Wheeler WS, Nicoloff JT (1982) Relationship of altered thyroid hormone indices to survival in nonthyroidal illness. Clin Endocrinol (Oxf) 16:565 Kaptein EM, Weiner JM, Robinson WJ, Wheeler WS, Nicoloff JT (1982) Relationship of altered thyroid hormone indices to survival in nonthyroidal illness. Clin Endocrinol (Oxf) 16:565
12.
go back to reference Slag MF, Morley JE, Elson MK, Crowson TW, Nuttall FQ, Shafer RB (1981) Hypothyroxinemia in critically ill patients as a predictor of high mortality. JAMA 245:43–45PubMed Slag MF, Morley JE, Elson MK, Crowson TW, Nuttall FQ, Shafer RB (1981) Hypothyroxinemia in critically ill patients as a predictor of high mortality. JAMA 245:43–45PubMed
13.
go back to reference Takala J, Ruokonen E, Webster NR, Nielsen MS, Zandstra DF, Vundelinckx G, Hinds CJ (1999) Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 341:785–792PubMed Takala J, Ruokonen E, Webster NR, Nielsen MS, Zandstra DF, Vundelinckx G, Hinds CJ (1999) Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 341:785–792PubMed
14.
go back to reference Meikle AW, Daynes RA, Araneo, BA (1991) Adrenal androgen secretion and biological effects. Endocrinol Metab Clin North Am 20:381–400PubMed Meikle AW, Daynes RA, Araneo, BA (1991) Adrenal androgen secretion and biological effects. Endocrinol Metab Clin North Am 20:381–400PubMed
15.
go back to reference Blauer KL, Poth M, Rogers WM, Bernton EW (1991) Dehydroepiandrosterone antagonizes the suppressive effects of dexamethasone on lymphocyte proliferation. Endocrinology 129:3174–3179PubMed Blauer KL, Poth M, Rogers WM, Bernton EW (1991) Dehydroepiandrosterone antagonizes the suppressive effects of dexamethasone on lymphocyte proliferation. Endocrinology 129:3174–3179PubMed
16.
go back to reference Suzuki T, Suzuki N, Daynes RA, Engleman EG (1991) Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T-cells. Clin Immunol Immunopathol 61:202–211PubMed Suzuki T, Suzuki N, Daynes RA, Engleman EG (1991) Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T-cells. Clin Immunol Immunopathol 61:202–211PubMed
17.
go back to reference Dahn MS, Mitchell RA, Smith S, Lange MP, Whitcomb MP, Kirkpatrick JR (1984) Altered immunological function and nitrogen metabolism associated with depression of plasma growth hormone. JPEN J Parenter Enteral Nutr 8:690–694PubMed Dahn MS, Mitchell RA, Smith S, Lange MP, Whitcomb MP, Kirkpatrick JR (1984) Altered immunological function and nitrogen metabolism associated with depression of plasma growth hormone. JPEN J Parenter Enteral Nutr 8:690–694PubMed
18.
go back to reference Dorshkind K, Horseman ND (2001) Anterior pituitary hormones, stress, and immune system homeostasis. Bioessays 23:288–294PubMed Dorshkind K, Horseman ND (2001) Anterior pituitary hormones, stress, and immune system homeostasis. Bioessays 23:288–294PubMed
19.
go back to reference Russell DH (1989) New aspects of prolactin and immunity: a lymphocyte-derived prolactin-like product and nuclear protein kinase C activation. Trends Pharmacol Sci 10:40–44PubMed Russell DH (1989) New aspects of prolactin and immunity: a lymphocyte-derived prolactin-like product and nuclear protein kinase C activation. Trends Pharmacol Sci 10:40–44PubMed
20.
go back to reference Noel GL, Suh HK, Stone JG, Frantz AG (1972) Human prolactin and growth hormone release during surgery and other conditions of stress. J Clin Endocrinol Metab 35:840–851PubMed Noel GL, Suh HK, Stone JG, Frantz AG (1972) Human prolactin and growth hormone release during surgery and other conditions of stress. J Clin Endocrinol Metab 35:840–851PubMed
21.
go back to reference Hosmer DW, Lemeshow S (2000) Applied logistic regression, 2nd edn. Wiley-Interscience, New York Hosmer DW, Lemeshow S (2000) Applied logistic regression, 2nd edn. Wiley-Interscience, New York
22.
go back to reference Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29–36PubMed Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29–36PubMed
23.
go back to reference McNeil BJ, Hanley JA (1984) Statistical approach to the analysis of receiver operating characteristic (ROC) curve. Med Decis Making 4:137–139PubMed McNeil BJ, Hanley JA (1984) Statistical approach to the analysis of receiver operating characteristic (ROC) curve. Med Decis Making 4:137–139PubMed
24.
go back to reference De Groot LJ (1999) Dangerous dogmas in medicine: the nonthyroidal illness syndrome. J Clin Endocrinol Metab 84:151–164PubMed De Groot LJ (1999) Dangerous dogmas in medicine: the nonthyroidal illness syndrome. J Clin Endocrinol Metab 84:151–164PubMed
25.
go back to reference Chernow B, Anderson DM (1985) Endocrine responses to critical illness. Semin Respir Med 7:1–10 Chernow B, Anderson DM (1985) Endocrine responses to critical illness. Semin Respir Med 7:1–10
26.
go back to reference Van den Berghe G (2001) The neuroendocrine response to stress is a dynamic process. Baillieres Best Pract Res Clin Endocrinol Metab 15:405–419 Van den Berghe G (2001) The neuroendocrine response to stress is a dynamic process. Baillieres Best Pract Res Clin Endocrinol Metab 15:405–419
27.
go back to reference Mechanick JI, Sacks HS, Cobin RH (1997) Hypothalamic-pituitary axis dysfunction in critically ill patients with a low free thyroxine index. J Endocrinol Invest 20:462–470PubMed Mechanick JI, Sacks HS, Cobin RH (1997) Hypothalamic-pituitary axis dysfunction in critically ill patients with a low free thyroxine index. J Endocrinol Invest 20:462–470PubMed
28.
go back to reference Leon-Sanz M, Lorente JA, Larrodera L, Ros P, Alvarez J, Esteban AE, Landin L (1997) Pituitary-thyroid function in patients with septic shock and its relation with outcome. Eur J Med Res 2:477–482PubMed Leon-Sanz M, Lorente JA, Larrodera L, Ros P, Alvarez J, Esteban AE, Landin L (1997) Pituitary-thyroid function in patients with septic shock and its relation with outcome. Eur J Med Res 2:477–482PubMed
29.
go back to reference Ray DC, Macduff A, Drummond GB, Wilkinson E, Adams B, Beckett GJ (2002) Endocrine measurements in survivors and non-survivors from critical illness. Intensive Care Med 28:1301–1308 Ray DC, Macduff A, Drummond GB, Wilkinson E, Adams B, Beckett GJ (2002) Endocrine measurements in survivors and non-survivors from critical illness. Intensive Care Med 28:1301–1308
30.
go back to reference Ray DC, Drummond GB, Wilkinson E, Beckett GJ (1995) Relationship of admission thyroid function tests to outcome in critical illness. Anaesthesia 50:1022–1025PubMed Ray DC, Drummond GB, Wilkinson E, Beckett GJ (1995) Relationship of admission thyroid function tests to outcome in critical illness. Anaesthesia 50:1022–1025PubMed
31.
go back to reference Vos RA, De Jong M, Bernard BF, Docter R, Krenning EP, Hennemann G (1995) Impaired thyroxine and 3,5,3′-triiodothyronine handling by rat hepatocytes in the presence of serum of patients with nonthyroidal illness. J Clin Endocrinol Metab 80:2364–2370PubMed Vos RA, De Jong M, Bernard BF, Docter R, Krenning EP, Hennemann G (1995) Impaired thyroxine and 3,5,3′-triiodothyronine handling by rat hepatocytes in the presence of serum of patients with nonthyroidal illness. J Clin Endocrinol Metab 80:2364–2370PubMed
32.
go back to reference Wolf M, Hansen N, Greten H (1994) Interleukin 1 beta, tumor necrosis factor-alpha and interleukin 6 decrease nuclear thyroid hormone receptor capacity in a liver cell line. Eur J Endocrinol 131:307–312PubMed Wolf M, Hansen N, Greten H (1994) Interleukin 1 beta, tumor necrosis factor-alpha and interleukin 6 decrease nuclear thyroid hormone receptor capacity in a liver cell line. Eur J Endocrinol 131:307–312PubMed
33.
go back to reference Wartofsky L, Burman KD (1982) Alterations in thyroid function in patients with systemic illness: “the euthyroid sick syndrome.” Endocr Rev 3:164–217 Wartofsky L, Burman KD (1982) Alterations in thyroid function in patients with systemic illness: “the euthyroid sick syndrome.” Endocr Rev 3:164–217
34.
go back to reference Chopra IJ, Teco GN, Nguyen AH, Solomon DH (1979) In search of an inhibitor of thyroid hormone binding to serum proteins in nonthyroidal illnesses. J Clin Endocrinol Metab 49:63–69PubMed Chopra IJ, Teco GN, Nguyen AH, Solomon DH (1979) In search of an inhibitor of thyroid hormone binding to serum proteins in nonthyroidal illnesses. J Clin Endocrinol Metab 49:63–69PubMed
35.
go back to reference Chopra IJ, Solomon DH, Teco GN, Eisenberg JB (1982) An inhibitor of the binding of thyroid hormones to serum proteins is present in extrathyroidal tissues. Science 215:407–409PubMed Chopra IJ, Solomon DH, Teco GN, Eisenberg JB (1982) An inhibitor of the binding of thyroid hormones to serum proteins is present in extrathyroidal tissues. Science 215:407–409PubMed
36.
go back to reference Span LF, Hermus AR, Bartelink AK, Hoitsma AJ, Gimbrere JS, Smals AG, Kloppenborg PW (1992) Adrenocortical function: an indicator of severity of disease and survival in chronic critically ill patients. Intensive Care Med 18:93–96PubMed Span LF, Hermus AR, Bartelink AK, Hoitsma AJ, Gimbrere JS, Smals AG, Kloppenborg PW (1992) Adrenocortical function: an indicator of severity of disease and survival in chronic critically ill patients. Intensive Care Med 18:93–96PubMed
37.
go back to reference Oppert M, Reinicke A, Graf KJ, Barckow D, Frei U, Eckardt KU (2000) Plasma cortisol levels before and during “low-dose” hydrocortisone therapy and their relationship to hemodynamic improvement in patients with septic shock. Intensive Care Med 26:1747–1755PubMed Oppert M, Reinicke A, Graf KJ, Barckow D, Frei U, Eckardt KU (2000) Plasma cortisol levels before and during “low-dose” hydrocortisone therapy and their relationship to hemodynamic improvement in patients with septic shock. Intensive Care Med 26:1747–1755PubMed
38.
go back to reference Vermes I, Beishuizen A, Hampsink RM, Haanen C (1995) Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients: possible role of endothelin and atrial natriuretic hormone. J Clin Endocrinol Metab 80:1238–1242PubMed Vermes I, Beishuizen A, Hampsink RM, Haanen C (1995) Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients: possible role of endothelin and atrial natriuretic hormone. J Clin Endocrinol Metab 80:1238–1242PubMed
39.
go back to reference Beishuizen A, Thijs LG, Vermes I (2001) Patterns of corticosteroid-binding globulin and the free cortisol index during septic shock and multitrauma. Intensive Care Med 27:1584–1591PubMed Beishuizen A, Thijs LG, Vermes I (2001) Patterns of corticosteroid-binding globulin and the free cortisol index during septic shock and multitrauma. Intensive Care Med 27:1584–1591PubMed
Metadata
Title
Thyroid hormone levels improve the prediction of mortality among patients admitted to the intensive care unit.
Authors
Erick Chinga-Alayo
Jaime Villena
Arthur T. Evans
Mirko Zimic
Publication date
01-10-2005
Publisher
Springer-Verlag
Published in
Intensive Care Medicine / Issue 10/2005
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-005-2719-9

Other articles of this Issue 10/2005

Intensive Care Medicine 10/2005 Go to the issue